With depressing nature of economy in many countries such as Nigeria where per capita income is low, there is need for utmost consideration for cost containment measures. Objective: The objective of this study is to conduct pharmacoeconomic evaluation of two antichlamydial indicated non-gonococcal urethritis therapeutic options and to make recommendations for inclusion of economic evaluation of drug therapies in health policy formulations and decision making. Results : The result shows that doxycycline costs N1.33/unit of effectiveness while tetracycline costs N2.77/unit of effectiveness in the treatment of chlamydial implicated non-gonococcal urethritis. Doxycycline is therefore more cost effective than tetracycline capsules. Subjecting the costs and effectiveness to sensitivity analysis did not change this conclusion. There is statistically significant difference in the effectiveness (outcome) of doxycycline (78.8%) and tetracycline (58.7%) ( x 2 =9.4; p<0.05) There is therefore association between effectiveness and therapeutic option chosen with doxycycline being a more cost-effective option. The result is significant because doxycycline is not currently included in the Essential Drug list of Nigeria 1 . However, the result is in agreement with Zimbabwean Essential Drug list which recommended that tetracycline be replaced by doxycycline in all indications and should be used only when doxycycline is not available 2 . Also doxycycline is a drug of choice for other disease like gonorrhorea and syphilis in non-pregnant women 2 . It was concluded that Doxycycline 100mg bd x 1 /52 is more cost effective than Tetracycline 500mg qid x 1 /52 in the treatment of chlamydial implicated non-gonococcal urethritis. Adoption of economic evaluation of drug therapies in Nigeria Health policy formulation and decisions is likely to enhance overall Health System cost effectiveness.
INTRODUCTION:
The advancement in medical technology (both diagnostic and therapeutic options) have complicated the financial burden of Health Systems. (Table 3) Definition of the goals and objective of problem situation: The objective was to determine which of the treatment options provide greater value for money for using effectiveness rating (Table 4) , decision analysis (Table 5 ) cost of therapy (Table 6 ) and cost effectiveness analysis table (Table 7) .
MATERIAL AND METHODS
Perspective: Economic perspective of the Health institution was chosen since the drugs were prescribed there.
However, patient perspective was considered where necessary.
Enumeration of the different ways to achieve the objective: (Table 4) Consideration of available/preferred treatment options was made between doxycycline and tetracycline.
Determination of cost of therapy
Only direct medical costs were included in the analysis. 
Consequences (Outcomes of each treatment option).
The literature was reviewed for positive and negative outcomes of each treatment options ( Physician office visit and patient traveling cost is assumed to be the same for both options. 
